Program for Evolutionary Dynamics, Department of Mathematics, Harvard University, Cambridge, MA 02138, USA.
J Mol Med (Berl). 2012 May;90(5):543-61. doi: 10.1007/s00109-012-0892-1. Epub 2012 May 3.
Infectious diseases remain a formidable challenge to human health, and understanding pathogen evolution is crucial to designing effective therapeutics and control strategies. Here, we review important evolutionary aspects of HIV infection, highlighting the concept of selection at multiple spatial and temporal scales. At the smallest scale, a single cell may be infected by multiple virions competing for intracellular resources. Recombination and phenotypic mixing introduce novel evolutionary dynamics. As the virus spreads between cells in an infected individual, it continually evolves to circumvent the immune system. We discuss evolutionary mechanisms of HIV pathogenesis and progression to AIDS. Viral spread throughout the human population can lead to changes in virulence and the transmission of immune-evading variation. HIV emerged as a human pathogen due to selection occurring between different species, adapting from related viruses of primates. HIV also evolves resistance to antiretroviral drugs within a single infected host, and we explore the possibility for the spread of these strains between hosts, leading to a drug-resistant epidemic. We investigate the role of latency, drug-protected compartments, and direct cell-to-cell transmission on viral evolution. The introduction of an HIV vaccine may select for viral variants that escape vaccine control, both within an individual and throughout the population. Due to the strong selective pressure exerted by HIV-induced morbidity and mortality in many parts of the world, the human population itself may be co-evolving in response to the HIV pandemic. Throughout the paper, we focus on trade-offs between costs and benefits that constrain viral evolution and accentuate how selection pressures differ at different levels of selection.
传染病仍然是人类健康的巨大挑战,了解病原体的进化对于设计有效的治疗方法和控制策略至关重要。在这里,我们回顾了 HIV 感染的重要进化方面,强调了在多个时空尺度上选择的概念。在最小的尺度上,单个细胞可能会被多个争夺细胞内资源的病毒粒子感染。重组和表型混合引入了新的进化动态。随着病毒在受感染个体的细胞之间传播,它不断进化以逃避免疫系统。我们讨论了 HIV 发病机制和进展为艾滋病的进化机制。病毒在整个人群中的传播会导致毒力的变化和免疫逃避变异的传播。HIV 作为一种人类病原体的出现是由于不同物种之间的选择,它从灵长类动物的相关病毒中适应而来。HIV 还在单个受感染宿主内对抗逆转录病毒药物产生抗药性,我们探讨了这些菌株在宿主之间传播导致耐药性流行的可能性。我们研究了潜伏、药物保护隔室和直接细胞间传播在病毒进化中的作用。HIV 疫苗的引入可能会选择逃避疫苗控制的病毒变异体,无论是在个体内部还是在整个人群中。由于 HIV 引起的发病率和死亡率在世界许多地区的强烈选择压力,人类人口本身可能会对 HIV 大流行做出反应而共同进化。在整篇论文中,我们重点关注限制病毒进化的成本和收益之间的权衡,并强调选择压力在不同选择水平上的差异。